Communiqués 4basebio PLC

Actions

4BB

GB00BMCLYF79

Recherche biotechnologique et médicale

Temps Différé London S.E. 10:15:17 17/09/2026			Varia. 5j.	Varia. 1 janv.
470,00 ^GBX	-2,08%		-2,08%	-23,58%

26/08	L'action 4basebio bondit après un nouvel accord marketing avec l'américain Genezen	AN
26/08	4basebio et Genezen s'associent dans l'ADN synthétique pour la production de vecteurs viraux	MT

Communiqués

07/09	4basebio Plc - 4basebio Expands DNA Offering to Meet Growing Demand for Personalised Medicine	PR
26/08	4basebio and Genezen Enter into Strategic Collaboration to Advance Synthetic, Cell-Free DNA Platforms for Next-Generation Viral Vector Manufacturing	GL
26/08	4basebio Plc - 4basebio Enters into Strategic Collaboration and Marketing Agreement with Genezen to Advance Synthetic, Cell-Free DNA Platforms for Next-Generation Viral Vector Manufacturing	PR
22/07	4basebio Plc - Grant of Options & Director/PDMR Dealing	PR
08/07	4basebio Plc - Director Appointment	PR
30/06	4basebio Plc - Result of AGM & Issue of Options	PR
16/06	4basebio Plc - Notice of Investor Presentation	PR
15/06	4basebio Appoints Dr. Jeff Coller to Strategic Advisory Board	AQ
15/06	4basebio Plc - 4basebio Appoints Dr. Jeff Coller to Strategic Advisory Board	PR
05/06	4basebio Plc - Notice of Annual General Meeting	PR
22/05	4basebio Plc - Director Dealing	PR
20/05	Final Results and Notice of AGM	AQ
20/05	4basebio Plc - Final Results and Notice of AGM	PR
20/05	4basebio Plc - 4basebio Signs Clinical Supply Agreement to Support Phase II Clinical Trial	PR
14/05	4basebio Announces Appointment of Chief Financial Officer and Board Changes	AQ
14/05	4basebio Plc - Appointment of Chief Financial Officer and Board Changes	PR
11/05	4basebio Launches Enzymatic ssDNA Platform	AQ
11/05	4basebio Plc - 4basebio Launches Enzymatic ssDNA Platform	PR
31/03	4basebio announces major expansion to support the growing demand of RUO and HQ synthetic DNA with lease of an innovation hub and manufacturing facility in Cambridge, UK	AQ
31/03	4basebio Plc - Lease of Manufacturing Facility	PR
12/03	4basebio Plc - Appointment of COO	PR
03/03	4basebio : strengthens commercial leadership, promoting Christine Wolosin to Chief Commercial Officer (Copy)	PU
03/03	4basebio : strengthens commercial leadership, promoting Christine Wolosin to Chief Commercial Officer	PU
03/03	4basebio Plc - Appointment of CCO	PR
16/02	4basebio Plc - Director Dealing	PR